Clinical Trial Update: Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating radiation therapy with or without bicalutamide and goserelin in patients with prostate cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Goserelin (Goserelin)
• bicalutamide (bicalutamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED